News
10-29-2024, 03:14 PM
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.
More... (https://www.news-medical.net/news/20241029/Researchers-develop-new-approach-to-predict-immunotherapy-response-in-breast-cancer-patients.aspx)
More... (https://www.news-medical.net/news/20241029/Researchers-develop-new-approach-to-predict-immunotherapy-response-in-breast-cancer-patients.aspx)